Conotoxins: Structure, therapeutic potential and pharmacological applications

Current Pharmaceutical Design

Volumn 22, Issue 5, 2016, Pages 582-589

  Mir, Rafia ^a   Karim, Sajjad ^b   Kamal, Mohammad Amjad ^b   Wilson, Cornelia M ^c   Mirza, Zeenat ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Classification; Conotoxins; Drugs; Structure

Indexed keywords

ALPHA CONOTOXIN EPI; ALPHA CONOTOXIN GI; AMINO ACID; CONOPEPTIDE; CONOTOXIN; LIGAND GATED ION CHANNEL; PEPTIDE; PROTEIN PRECURSOR; SNAIL VENOM; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; ION CHANNEL; LIGAND;

ANALYTIC METHOD; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CLINICAL CLASSIFICATION; CONCEPTUAL FRAMEWORK; CRYSTAL STRUCTURE; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; GLYCOSYLATION; HUMAN; MARINE SNAIL; NONHUMAN; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; ANTAGONISTS AND INHIBITORS; CHEMISTRY; METABOLISM; NEOPLASMS; SCIATICA;

CONOTOXINS; HUMANS; ION CHANNELS; LIGANDS; NEOPLASMS; SCIATICA;

EID: 84958242104     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151124234715     Document Type: Article

References (67)

1. Harvey AL. Toxins 'R' Us: more pharmacological tools from nature's superstore. Trend Pharmacol Sci 2002; 23 (5): 201-3.
2. Olivera BM, Cruz LJ. Conotoxins, in retrospect. Toxicon J Int Soc Toxinol 2001; 39 (1): 7-14.
3. Cruz LJ, Gray WR, Yoshikami D, Olivera BM. Conus venoms: a rich source of neuroactive peptides. Toxin Rev 1985; 4 (2): 107-32.
4. Gray WR, Olivera BM, Cruz LJ. Peptide toxins from venomous Conus snails. Annl Rev Biochem 1988; 57 665-700.
5. McIntosh JM, Santos AD, Olivera BM. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Ann Rev Biochem 1999; 68 59-88.
6. Terlau H, Olivera BM. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev 2004; 84 (1): 41-68.
7. Puillandre N, Koua D, Favreau P, Olivera BM, Stocklin R. Molecular phylogeny, classification and evolution of conopeptides. J Mol Evol 2012; 74 (5-6): 297-309.
8. Olivera BM. CONUS VENOM PEPTIDES: Reflections from the Biology of Clades and Species. Ann Rev Ecol Syst 2002; 33 (1): 25-47.
9. Woodward SR, Cruz LJ, Olivera BM, Hillyard DR. Constant and hypervariable regions in conotoxin propeptides. EMBO J 1990; 9 (4): 1015-20.
10. Kaas Q, Westermann JC, Craik DJ. Conopeptide characterization and classifications: an analysis using ConoServer. Toxicon J Int Soc Toxinol 2010; 55 (8): 1491-509.
11. Kaas Q, Yu R, Jin AH, Dutertre S, Craik DJ. ConoServer: updated content, knowledge, and discovery tools in the conopeptide database. Nucleic Acids Res 2012; 40 (Database issue): D325-30.
12. Kaas Q, Westermann JC, Halai R, Wang CK, Craik DJ. ConoServer, a database for conopeptide sequences and structures. Bioinformatics (Oxford, England) 2008; 24 (3): 445-6.
13. Balaji RA, Ohtake A, Sato K, et al. lambda-conotoxins, a new family of conotoxins with unique disulfide pattern and protein folding. Isolation and characterization from the venom of Conus marmoreus. J Biol Chem 2000; 275 (50): 39516-22.
14. Adams DJ, Alewood PF, Craik DJ, Drinkwater RD, Lewis RJ. Conotoxins and their potential pharmaceutical applications. Drug Develop Res 1999; 46 (3-4): 219-34.
15. Lewis RJ. Conotoxins: molecular and therapeutic targets. Prog Mol Subcell Biol 2009; 46: 45-65.
16. Lewis RJ, Dutertre S, Vetter I, Christie MJ. Conus venom peptide pharmacology. Pharmacol Rev 2012; 64 (2): 259-98.
17. Davis J, Jones A, Lewis RJ. Remarkable inter- and intra-species complexity of conotoxins revealed by LC/MS. Peptides 2009; 30 (7): 1222-7.
18. Dutertre S, Biass D, Stocklin R, Favreau P. Dramatic intraspecimen variations within the injected venom of Conus consors: an unsuspected contribution to venom diversity. Toxicon 2010; 55 (8): 1453-62.
19. Romeo C, Di Francesco L, Oliverio M, et al. Conus ventricosus venom peptides profiling by HPLC-MS: a new insight in the intraspecific variation. J Separation Sci 2008; 31 (3): 488-98.
20. Rivera-Ortiz JA, Cano H, Mari F. Intraspecies variability and conopeptide profiling of the injected venom of Conus ermineus. Peptides 2011; 32 (2): 306-16.
21. Pisarewicz K, Mora D, Pflueger FC, Fields GB, Mari F. Polypeptide chains containing D-gamma-hydroxyvaline. J Am Chem Soc 2005; 127 (17): 6207-15.
22. Walker CS, Jensen S, Ellison M, et al. A novel Conus snail polypeptide causes excitotoxicity by blocking desensitization of AMPA receptors. Curr Biol 2009; 19 (11): 900-8.
23. Daly NL, Craik DJ. Structural studies of conotoxins. IUBMB Life 2009; 61 (2): 144-50.
24. McIntosh JM, Dowell C, Watkins M, et al. Conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors. J Biol Chem 2002; 277 (37): 33610-5.
25. Craig AG, Bandyopadhyay P, Olivera BM. Post-translationally modified neuropeptides from Conus venoms. Eur J Biochem 1999; 264 (2): 271-5.
26. Buczek O, Bulaj G, Olivera BM. Conotoxins and the posttranslational modification of secreted gene products. Cellular Mol Life Sci 2005; 62 (24): 3067-79.
27. Peter-Katalini J, Methods in Enzymology: O-Glycosylation of Proteins. In: Burlingame AL, Ed. Methods in Enzymology. USA: Academic Press 2005; Vol. 405: pp 139-71.
28. Craig AG, Zafaralla G, Cruz LJ, et al. An O-glycosylated neuroexcitatory conus peptide. Biochemistry 1998; 37 (46): 16019-25.
29. Craig AG, Norberg T, Griffin D, et al. Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem 1999; 274 (20): 13752-9.
30. Brockhausen I SH, Stanley P. O-GalNAc Glycans. Chapter 9. Cold Spring Harbor New York, USA: Cold Spring Harbor Laboratory Press 2009.
31. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999; 1473 (1): 67-95.
32. Varki A LJ, Chapter 6, Biological Roles of Glycans. New York, USA: Cold Spring Harbor 2009.
33. Taylor MED K., Introduction to Glycobiology, 3rd ed. Oxford, UK: Oxford University Press 2011.
34. Craig AG. The characterization of conotoxins. Toxin Rev 2000; 19 (1): 53-93.
35. Bulaj G, Olivera BM. Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides. Antioxidants Redox Signal 2008; 10 (1): 141-55.
36. Kindahl L, Sandström C, Craig AG, Norberg T, Kenne L. 1H NMR studies on the solution conformation of contulakin-G and analogues. Canadian J Chem 2002; 80 (8): 1022-31.
37. Kang J, Low W, Norberg T, et al. Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post-translationally modified conotoxin, reveals that the glycan structure is -d-Gal-(1 3)-d-GalNAc. Eur J Biochem 2004; 271 (23-24): 4939-49.
38. Marx UC, Daly NL, Craik DJ. NMR of conotoxins: structural features and an analysis of chemical shifts of post-translationally modified amino acids. Magnet Reson Chem 2006; 44: S41-50.
39. Gerwig G, Hocking H, Stöcklin R, Kamerling J, Boelens R. Glycosylation of Conotoxins. Marine Drug 2013; 11 (3): 623.
40. Craik DJ, Daly NL, Waine C. The cystine knot motif in toxins and implications for drug design. Toxicon 2001; 39 (1): 43-60.
41. Cheek S, Krishna SS, Grishin NV. Structural classification of small, disulfide-rich protein domains. J Mol Biol 2006; 359 (1): 215-37.
42. Olivera BM, Cruz LJ, de Santos V, et al. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry 1987; 26 (8): 2086-90.
43. McIntosh JM, Hasson A, Spira ME, et al. A new family of conotoxins that blocks voltage-gated sodium channels. J Biol Chem 1995; 270 (28): 16796-802.
44. Gehrmann J, Alewood PF, Craik DJ. Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability. J Mol Biol 1998; 278 (2): 401-15.
45. Hu SH, Gehrmann J, Alewood PF, Craik DJ, Martin JL. Crystal structure at 1.1 A resolution of alpha-conotoxin PnIB: comparison with alpha-conotoxins PnIA and GI. Biochemistry 1997; 36 (38): 11323-30.
46. Skjaerbaek N, Nielsen KJ, Lewis RJ, Alewood P, Craik DJ. Determination of the solution structures of conantokin-G and conantokin-T by CD and NMR spectroscopy. J Bio Chem 1997; 272 (4): 2291-9.
47. Guddat LW, Martin JA, Shan L, Edmundson AB, Gray WR. Three-dimensional structure of the alpha-conotoxin GI at 1.2 A resolution. Biochemistry 1996; 35 (35): 11329-35.
48. Hu SH, Loughnan M, Miller R, et al. The 1.1 A resolution crystal structure of [Tyr15]EpI, a novel alpha-conotoxin from Conus episcopatus, solved by direct methods. Biochemistry 1998; 37 (33): 11425-33.
49. Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nature reviews. Drug Discov 2003; 2 (10): 790-802.
50. Olivera BM, Cruz LJ, Yoshikami D. Effects of Conus peptides on the behavior of mice. Curr Opin Neurobiol 1999; 9 (6): 772-7.
51. Tsetlin VI, Hucho F. Snake and snail toxins acting on nicotinic acetylcholine receptors: fundamental aspects and medical applications. FEBS Lett 2004; 557 (1-3): 9-13.
52. Celie PH, Kasheverov IE, Mordvintsev DY, et al. Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant. Nat Struct Mol Biol 2005; 12 (7): 582-8.
53. Ulens C, Hogg RC, Celie PH, et al. Structural determinants of selective -conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP. Proc Natl Acad Sci USA 2006; 103 (10): 3615-20.
54. Dutertre S, Ulens C, Buttner R, et al. AChBP-targeted alphaconotoxin correlates distinct binding orientations with nAChR subtype selectivity. EMBO J 2007; 26 (16): 3858-67.
55. Azam L, McIntosh JM. Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta Pharmacol Sin 2009; 30 (6): 771-783.
56. Klint JK, Senff S, Rupasinghe DB, et al. Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads. Toxicon 2012; 60 (4): 478-91.
57. Livett BG, Gayler KR, Khalil Z. Drugs from the sea: conopeptides as potential therapeutics. Curr Med Chem 2004; 11 (13): 1715-23.
58. Buckingham SD, Jones AK, Brown LA, Sattelle DB. Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 2009; 61 (1): 39-61.
59. White HS, McCabe RT, Armstrong H, et al. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J Pharmacol exp ther 2000; 292 (1): 425-32.
60. Olivera BM, Imperial JS, Concepcion GP, Snail Peptides. Chapter 61. In: Kastin AJ, Ed. Handbook of Biologically Active Peptides (Second Edition), Boston: Academic Press 2013; pp 437-50.
61. Satkunanathan N, Livett B, Gayler K, et al. Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Brain Res 2005; 1059 (2): 149-58.
62. Wilson MJ, Yoshikami D, Azam L, et al. mu-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve. Proc Natl Acad Sci USA 2011; 108 (25): 10302-7.
63. Imperial JS, Silverton N, Olivera BM, et al. Using chemistry to reconstruct evolution: on the origins of fish-hunting in venomous cone snails. Proc Am Philos Soc 2007; 151 (2): 185-200.
64. Kress HG, Simpson KH, Marchettini P, Ver Donck A, Varrassi G. Intrathecal therapy: what has changed with the introduction of ziconotide. Pain Pract 2009; 9 (5): 338-47.
65. Staats PS, Yearwood T, Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004; 291 (1): 63-70.
66. Sharpe IA, Gehrmann J, Loughnan ML, et al. Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter. Nat Neurosci 2001; 4 (9): 902-7.
67. Puillandre N, Bouchet P, Duda TF, Jr., et al. Molecular phylogeny and evolution of the cone snails (Gastropoda, Conoidea). Mol phylogenet Evol 2014; 78 290-303.